Navigation Links
Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
Date:1/24/2011

ldwide Neulasta® (pegfilgrastim) and NEUPOGEN® (Filgrastim) sales increased 3 percent to $1,237 million in the fourth quarter of 2010 versus $1,202 million in the fourth quarter of 2009.  Combined U.S. Neulasta and NEUPOGEN sales increased 4 percent to $914 million in the fourth quarter of 2010 versus $880 million in the fourth quarter of 2009, primarily driven by an increase in the average net sales price, and to a lesser extent, favorable changes in wholesaler inventories.  Combined Neulasta and NEUPOGEN international sales were $323 million in the fourth quarter of 2010 versus $322 million in the fourth quarter of 2009.  Excluding foreign exchange impact, international Neulasta and NEUPOGEN product sales increased 2 percent, reflecting growth in Neulasta primarily from continued conversion of NEUPOGEN to Neulasta, partially offset by a decline in NEUPOGEN as a result of biosimilar competition. For the year, combined worldwide Neulasta and NEUPOGEN sales increased 4 percent to $4,844 million in 2010 versus $4,643 million in 2009, principally driven by an increase in the U.S. average net sales price, and to a lesser extent, favorable changes in U.S. wholesaler inventories.

Enbrel® (etanercept) sales increased 3 percent to $939 million in the fourth quarter of 2010 versus $912 million in the fourth quarter 2009. For the year, ENBREL sales increased 1 percent to $3,534 million in 2010 versus $3,493 million in 2009. In the fourth quarter of 2010, the mid single-digit decline in unit demand, due to share declines primarily in dermatology, was offset by an increase in the average net sales price.  ENBREL continues to maintain a leading position in both the rheumatology and dermatology segments.  

Worldwide sales of Sensipar® / Mimpara® (cinacalcet) increased 10 percent to $188 million in the fourth quarter of 2010 versus $171 million in the fourth quart
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. PLC Systems Reports Fourth Quarter 2007 Results
5. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
6. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
7. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
8. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
9. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
11. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  BioLife Solutions, Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and cryopreservation ... for cells and tissues ("BioLife" or the "Company"), announced that ... MicroCap Conference. The Company is scheduled to ... May 27, 2015 at the Grand Hyatt Hotel in ...
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx Biopharmaceuticals, ... on tissue protection, repair and regeneration, today announced that ... is scheduled to present a corporate overview at two ... present at the SeeThruEquity 4 th Annual Microcap ... New York City at 11:00 am EDT. ...
(Date:5/22/2015)... -- According to a new market research ... Services), by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species ... Users - Global Forecast to 2020", published by MarketsandMarkets, the ... $736.85 Million by 2020 from $452.36 Million in 2015, ... Browse 71 market data Tables and 90 Figures spread ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4
... Jan. 20, 2011 Aubrey Inc. – http://www.aubreyinc.com ... and product evaluation phase of its second generation product, ... production and currently available for purchase.  Founder Aubrey Woodroof, ... advance the art once again.  "It is a wonderful ...
... FRANCISCO, Jan. 20, 2011 TheCarrot.com , ... health engagement programs, announced the immediate availability of ... expertise of the University of California at San ... combines proven behavior modification methodology with TheCarrot.com,s award-winning ...
Cached Medicine Technology:Aubrey Inc. Releases New Advanced Biosynthetic Wound Care Product 'AWBAT Plus' 2TheCarrot.com Launches Quit Smoking Program 2TheCarrot.com Launches Quit Smoking Program 3
(Date:5/22/2015)... 2015 Combination therapy, or polytherapy, ... chronic obstructive pulmonary disorder (COPD) as the dominant ... plc as well as Germany’s Boehringer Ingelheim compete ... But will market payers, clinicians and patients be ... to completely new ones? , In spite of ...
(Date:5/22/2015)... Carnegie Science Center and ... new partnership to develop BodyTech, a dynamic, three-pronged health ... includes a new exhibit at the Science Center called ... a new traveling science show, Anatomy Adventure, which will ... , Designed to explore a wide range of topics ...
(Date:5/22/2015)... 22, 2015 Power Systems is proud to ... 2015 race season. Drobeck is in his second year of ... firefighter with the Missoula Fire Department in Missoula, MT. He ... in 2014. During his career, he has had 15 1st ... recorded top 10 finishes in all seven of his 2014 ...
(Date:5/22/2015)... 2015 The dentist in ... that they are now offering complimentary consultations to ... treatments. At consultations, patients can discuss their candidacy ... certain treatments can achieve and whether alternative options ... initial appointment. If treatments are chosen, patients can ...
(Date:5/22/2015)... 2015 A Phase 3 French ... Society of Clinical Oncology (ASCO)’s annual meeting at ... for those patients who received bevacizumab in addition ... Bevacizumab (Avastin® Genentech, Inc.) is an antibody that ... already routinely used to treat many other cancers, ...
Breaking Medicine News(10 mins):Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2
... A survey conducted among many Canadian households has revealed ... unable to realize timely medical guidance and facilities,// especially ... ,The Decima poll conducted amongst 3,000 Canadians has shown ... during the previous three months and felt the waiting ...
... Disease Laboratory in Bhopal have finally helped to materialize India's ... H5N1 bird flu virus last month. However, several obstacles lay ... vaccine. ,This is because there is not a ... poultry who has a Bio Safety Level (BSL) 3 lab, ...
... of strategies to combat cervical abnormalities; the worlds first ever ... the market. , ,A feather in the cap ... brain behind this vaccine, who has relentlessly worked on this ... the inaugural shot. This vaccine is powerful in containing the ...
... online interaction between Britain and India, British pupils are ... on various subjects from teachers based in India.// ... one-to-one tuition using Internet telephony from TutorVista, a company ... in shifts. ,While such services have been ...
... awarded a 63-year-old doctor of Indian origin a four-year ... patients over a 13-year //period between September 1991 and ... qualified in India, moved to Britain in 1973. He ... His one-man practice had 2,900 patients. He began his ...
... Board (MPPEB) will hold afresh next month the Dental and ... dental colleges. // ,The test conducted Aug 13 ... probed the complaints cancelled the examination Aug 19. ... examinations in a way so that the results can be ...
Cached Medicine News:Health News:Major Hurdle towards Development of Bird Flu Vaccine in India. 2Health News:British Pupils Opt for Online Tuition from India 2Health News:Indian Doctor in Britain Jailed for Molesting Patients 2
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
... table comes in two modelsthe BT4, which ... BT5, which offers five. With the simple ... to suit your needs. Both models ... side rails, ankle/foot supports, adjustable arm boards, ...
The design of this table top is based on advanced functionality for specific urological requirements. This composite product sets a new standard for urological imaging....
5 Part Differential Auto Hematology Analyzer.,Top of the range Cell Counter for medium-sized laboratories....
Medicine Products: